We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HTBX market cap is 62.08M. The company's latest EPS is USD -1.7336 and P/E is -0.16.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 723k | 4.85M | 4.51M | 760k | 1.03M |
| Operating Income | -8.35M | -6.44M | -5.32M | -8.7M | -9.75M |
| Net Income | -13.13M | -5.41M | -4.42M | -8.87M | -10.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.05M | 2.95M | 2.11M | 9.84M | 7M |
| Operating Income | -20.75M | -24.93M | -34.99M | -45.69M | -42.03M |
| Net Income | -20.02M | -26.05M | -35.07M | -43.44M | -45.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 69.92M | 51.04M | 50.5M | 46.69M | 46.54M |
| Total Liabilities | 36.47M | 22.74M | 25.25M | 24.83M | 21.99M |
| Total Equity | 33.45M | 28.3M | 25.26M | 21.86M | 24.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.96M | 124.2M | 120.96M | 104.4M | 51.04M |
| Total Liabilities | 12.8M | 8.7M | 8.93M | 31.96M | 22.74M |
| Total Equity | 13.16M | 115.49M | 112.03M | 72.44M | 28.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.46M | -31.53M | -4.68M | -11.22M | -20.72M |
| Investing | 30.14M | 32.24M | 2.78M | 3.04M | 2.83M |
| Financing | -2.75M | -8.95M | 3.28M | 9.47M | 22.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.84M | -22.02M | -38.13M | -5.7M | -31.53M |
| Investing | -293k | -95.42M | 9.77M | 10.99M | 32.24M |
| Financing | 19k | 119.33M | 25.49M | -4.91M | -8.95M |
| Market Cap | 62.08M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 1.04 |
| Price to Cash Ratio | 39.44 |
| Price to Book Ratio | 0.26 |
| Dividend Yield | - |
| Shares Outstanding | 26.08M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.22 (8.98%) |
| Company Name | Heat Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ir.scorpiusbiologics.com/ |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
